Showing 21-27 of 27 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| In vivo analysis of human islet graft infiltration and its immunomodulation by antigen-specific therapy | Trustees of Columbia University in the City of New York | Remi Creusot | Cures | 01-August-2022 to 31-July-2025 | $699,995.75 |
| Improving pig islet transplant efficacy in a preclinical baboon diabetes model with induced immune tolerance to the xenografts | Trustees of Columbia University in the City of New York | Megan Sykes | Cures | 01-June-2024 to 31-May-2026 | $599,999.94 |
| Achieving persistent presentation of self-antigens to reestablish tolerance and prevent autoimmune diabetes | Trustees of Columbia University in the City of New York | Camillo Bechi Genzano | Cures | 01-March-2025 to 29-February-2028 | $256,285.00 |
| Chemical Perturb-seq to identify small molecules controlling the maturation and survival on human beta cells | Weill Medical College of Cornell University | Xiaoshan Zhang | Cures | 01-March-2026 to 28-February-2029 | $256,285.00 |
| Co-transplantation of adaptive human endothelium and islets within encapsulated angiogenic hydrogels for durable engraftment | Weill Medical College of Cornell University | Shahin Rafii | Cures | 01-December-2023 to 30-November-2026 | $1,000,000.00 |
| Role of oxidative post-translational modifications in generating neoepitopes | Weill Medical College of Cornell University | Laura Santambrogio | Cures | 01-April-2025 to 31-March-2028 | $600,000.00 |
| Intrinsic Tolerance in GINS: Dissecting the HVEM/BTLA Axis Driving Hypoimmunogenicity | Weill Medical College of Cornell University | Anna Ada Dattoli | Cures | 01-April-2026 to 31-March-2027 | $199,999.32 |